Cabaletta Bio Inc (CABA)
12.34
-0.28
(-2.22%)
USD |
NASDAQ |
May 17, 16:00
12.67
+0.33
(+2.67%)
After-Hours: 20:00
Cabaletta Bio Total Assets (Quarterly): 240.46M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 240.46M |
| December 31, 2023 | 253.65M |
| September 30, 2023 | 173.29M |
| June 30, 2023 | 184.64M |
| March 31, 2023 | 103.45M |
| December 31, 2022 | 116.97M |
| September 30, 2022 | 91.68M |
| June 30, 2022 | 102.02M |
| March 31, 2022 | 113.66M |
| December 31, 2021 | 126.34M |
| September 30, 2021 | 122.64M |
| Date | Value |
|---|---|
| June 30, 2021 | 106.93M |
| March 31, 2021 | 107.28M |
| December 31, 2020 | 114.72M |
| September 30, 2020 | 121.77M |
| June 30, 2020 | 127.90M |
| March 31, 2020 | 134.96M |
| December 31, 2019 | 141.47M |
| September 30, 2019 | 74.94M |
| June 30, 2019 | 77.84M |
| December 31, 2018 | 34.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.94M
Minimum
Sep 2019
253.65M
Maximum
Dec 2023
131.83M
Average
119.37M
Median
Total Assets (Quarterly) Benchmarks
| Editas Medicine Inc | 440.35M |
| ACADIA Pharmaceuticals Inc | 855.10M |
| Alnylam Pharmaceuticals Inc | 3.824B |
| Regeneron Pharmaceuticals Inc | 34.37B |
| Vertex Pharmaceuticals Inc | 23.92B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.74M |
| Shareholders Equity (Quarterly) | 221.72M |